

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of histone deacetylation (GO:0031065) | 4.70037229 |
| 2 | positive regulation of prostaglandin secretion (GO:0032308) | 4.48814938 |
| 3 | negative regulation of cell size (GO:0045792) | 3.91978572 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.80597318 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.80597318 |
| 6 | regulation of prostaglandin secretion (GO:0032306) | 3.77367766 |
| 7 | apoptotic cell clearance (GO:0043277) | 3.70252891 |
| 8 | regulation of cholesterol homeostasis (GO:2000188) | 3.61674393 |
| 9 | N-acetylneuraminate metabolic process (GO:0006054) | 3.60343476 |
| 10 | maternal placenta development (GO:0001893) | 3.58027642 |
| 11 | protein localization to endosome (GO:0036010) | 3.50849277 |
| 12 | regulation of cholesterol storage (GO:0010885) | 3.43603489 |
| 13 | low-density lipoprotein particle clearance (GO:0034383) | 3.41230199 |
| 14 | positive regulation of protein deacetylation (GO:0090312) | 3.36689186 |
| 15 | positive regulation of icosanoid secretion (GO:0032305) | 3.33310200 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31150876 |
| 17 | regulation of somitogenesis (GO:0014807) | 3.30110798 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23071949 |
| 19 | negative regulation of catenin import into nucleus (GO:0035414) | 3.21975732 |
| 20 | positive regulation of fatty acid transport (GO:2000193) | 3.21716941 |
| 21 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.15560783 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 3.15206087 |
| 23 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.14326631 |
| 24 | stress fiber assembly (GO:0043149) | 3.12602044 |
| 25 | regulation of fatty acid transport (GO:2000191) | 3.11896527 |
| 26 | response to muramyl dipeptide (GO:0032495) | 3.10838325 |
| 27 | plasma membrane repair (GO:0001778) | 3.10713608 |
| 28 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.09003388 |
| 29 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.07200108 |
| 30 | pentose-phosphate shunt (GO:0006098) | 3.05302410 |
| 31 | mannose metabolic process (GO:0006013) | 3.04475971 |
| 32 | apoptotic process involved in morphogenesis (GO:0060561) | 3.04425554 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03559318 |
| 34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.02678586 |
| 35 | endothelial cell chemotaxis (GO:0035767) | 3.01943963 |
| 36 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.01361832 |
| 37 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.99082136 |
| 38 | positive thymic T cell selection (GO:0045059) | 2.97743363 |
| 39 | positive regulation of nuclease activity (GO:0032075) | 2.97718599 |
| 40 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.96868393 |
| 41 | negative regulation of fatty acid transport (GO:2000192) | 2.92580781 |
| 42 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.92240988 |
| 43 | regulation of p38MAPK cascade (GO:1900744) | 2.90301705 |
| 44 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.89569469 |
| 45 | macrophage activation involved in immune response (GO:0002281) | 2.89071516 |
| 46 | lytic vacuole organization (GO:0080171) | 2.88962528 |
| 47 | lysosome organization (GO:0007040) | 2.88962528 |
| 48 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.86326316 |
| 49 | regulation of early endosome to late endosome transport (GO:2000641) | 2.85350995 |
| 50 | response to laminar fluid shear stress (GO:0034616) | 2.85218482 |
| 51 | negative regulation of heart growth (GO:0061117) | 2.84223859 |
| 52 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.84223859 |
| 53 | negative regulation of macroautophagy (GO:0016242) | 2.83845147 |
| 54 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.82228520 |
| 55 | negative regulation of cell killing (GO:0031342) | 2.82228520 |
| 56 | cell-substrate junction assembly (GO:0007044) | 2.80775628 |
| 57 | 4-hydroxyproline metabolic process (GO:0019471) | 2.79484993 |
| 58 | amino sugar catabolic process (GO:0046348) | 2.78865684 |
| 59 | response to peptidoglycan (GO:0032494) | 2.77531066 |
| 60 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.76467545 |
| 61 | negative regulation of interleukin-12 production (GO:0032695) | 2.75768515 |
| 62 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74385389 |
| 63 | regulation of ARF GTPase activity (GO:0032312) | 2.73589216 |
| 64 | endothelial tube morphogenesis (GO:0061154) | 2.73287524 |
| 65 | morphogenesis of an endothelium (GO:0003159) | 2.73287524 |
| 66 | macroautophagy (GO:0016236) | 2.72750257 |
| 67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.72014452 |
| 68 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.70587265 |
| 69 | receptor catabolic process (GO:0032801) | 2.70535874 |
| 70 | positive regulation of antigen processing and presentation (GO:0002579) | 2.69584717 |
| 71 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.69539131 |
| 72 | adherens junction assembly (GO:0034333) | 2.69197167 |
| 73 | regulation of nuclease activity (GO:0032069) | 2.67352904 |
| 74 | regulation of icosanoid secretion (GO:0032303) | 2.67250183 |
| 75 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.65954964 |
| 76 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.65737682 |
| 77 | positive regulation of p38MAPK cascade (GO:1900745) | 2.65486333 |
| 78 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.65212410 |
| 79 | regulation of integrin activation (GO:0033623) | 2.64988390 |
| 80 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.64972970 |
| 81 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.64587304 |
| 82 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.62151167 |
| 83 | epithelial cell-cell adhesion (GO:0090136) | 2.62106003 |
| 84 | regulation of gamma-delta T cell activation (GO:0046643) | 2.61820059 |
| 85 | germinal center formation (GO:0002467) | 2.61620010 |
| 86 | negative regulation of lipid transport (GO:0032369) | 2.60896789 |
| 87 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.60601725 |
| 88 | regulation of mast cell degranulation (GO:0043304) | 2.59927962 |
| 89 | 2-oxoglutarate metabolic process (GO:0006103) | 2.59201313 |
| 90 | peptidyl-lysine dimethylation (GO:0018027) | 2.57749736 |
| 91 | barbed-end actin filament capping (GO:0051016) | 2.56945234 |
| 92 | regulation of hippo signaling (GO:0035330) | 2.56762381 |
| 93 | regulation of leukocyte degranulation (GO:0043300) | 2.55814184 |
| 94 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.55522797 |
| 95 | growth hormone receptor signaling pathway (GO:0060396) | 2.55506717 |
| 96 | regulation of translational fidelity (GO:0006450) | 2.55278013 |
| 97 | histone H4 deacetylation (GO:0070933) | 2.55230492 |
| 98 | COPI coating of Golgi vesicle (GO:0048205) | 2.54790819 |
| 99 | Golgi transport vesicle coating (GO:0048200) | 2.54790819 |
| 100 | tricarboxylic acid metabolic process (GO:0072350) | 2.53450125 |
| 101 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.52828349 |
| 102 | NADPH regeneration (GO:0006740) | 2.52123465 |
| 103 | focal adhesion assembly (GO:0048041) | 2.51288168 |
| 104 | cell-substrate adherens junction assembly (GO:0007045) | 2.51288168 |
| 105 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51283741 |
| 106 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51283741 |
| 107 | modulation by symbiont of host immune response (GO:0052553) | 2.51283741 |
| 108 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51283741 |
| 109 | modulation by symbiont of host defense response (GO:0052031) | 2.51283741 |
| 110 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51283741 |
| 111 | positive regulation of protein kinase C signaling (GO:0090037) | 2.50675128 |
| 112 | regulation of monocyte differentiation (GO:0045655) | 2.50314932 |
| 113 | regulation of fatty acid oxidation (GO:0046320) | 2.50009732 |
| 114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.49597668 |
| 115 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49331633 |
| 116 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.48440352 |
| 117 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.47664133 |
| 118 | defense response to protozoan (GO:0042832) | 2.46837896 |
| 119 | sexual reproduction (GO:0019953) | 2.46796215 |
| 120 | cell-cell junction maintenance (GO:0045217) | 2.46737184 |
| 121 | protein retention in ER lumen (GO:0006621) | 2.46466555 |
| 122 | amyloid precursor protein catabolic process (GO:0042987) | 2.46450918 |
| 123 | positive T cell selection (GO:0043368) | 2.45109440 |
| 124 | sodium ion export (GO:0071436) | 2.44509788 |
| 125 | T cell selection (GO:0045058) | 2.43799604 |
| 126 | histone H3 deacetylation (GO:0070932) | 2.43616327 |
| 127 | positive regulation of Rap GTPase activity (GO:0032854) | 2.43279435 |
| 128 | B cell receptor signaling pathway (GO:0050853) | 2.43197788 |
| 129 | regulation of histone deacetylation (GO:0031063) | 2.42865350 |
| 130 | lysine metabolic process (GO:0006553) | 2.42381654 |
| 131 | lysine catabolic process (GO:0006554) | 2.42381654 |
| 132 | positive regulation of lipid storage (GO:0010884) | 2.41735501 |
| 133 | heterochromatin organization (GO:0070828) | 2.41510126 |
| 134 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.41417134 |
| 135 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.40840894 |
| 136 | regulation of mast cell activation (GO:0033003) | 2.39339445 |
| 137 | cellular response to unfolded protein (GO:0034620) | 2.39138275 |
| 138 | response to protozoan (GO:0001562) | 2.37879422 |
| 139 | cellular response to exogenous dsRNA (GO:0071360) | 2.37702245 |
| 140 | activation of JUN kinase activity (GO:0007257) | 2.36563369 |
| 141 | positive regulation of lamellipodium assembly (GO:0010592) | 2.35678418 |
| 142 | negative regulation of interleukin-6 production (GO:0032715) | 2.35304623 |
| 143 | carnitine shuttle (GO:0006853) | 2.35224659 |
| 144 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.34723179 |
| 145 | skin morphogenesis (GO:0043589) | 2.34713108 |
| 146 | semaphorin-plexin signaling pathway (GO:0071526) | 2.34304909 |
| 147 | cortical actin cytoskeleton organization (GO:0030866) | 2.34074890 |
| 148 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.33598408 |
| 149 | regulation of translational termination (GO:0006449) | 2.33295558 |
| 150 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.33177185 |
| 151 | regulation of antigen processing and presentation (GO:0002577) | 2.32930796 |
| 152 | thymic T cell selection (GO:0045061) | 2.32281417 |
| 153 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.32031963 |
| 154 | natural killer cell differentiation (GO:0001779) | 2.31883482 |
| 155 | tolerance induction (GO:0002507) | 2.31845785 |
| 156 | hematopoietic stem cell proliferation (GO:0071425) | 2.31371952 |
| 157 | ER-nucleus signaling pathway (GO:0006984) | 2.31000765 |
| 158 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.30307241 |
| 159 | fatty acid transmembrane transport (GO:1902001) | 2.29877753 |
| 160 | negative regulation of granulocyte differentiation (GO:0030853) | 2.27597620 |
| 161 | negative regulation of innate immune response (GO:0045824) | 2.27204642 |
| 162 | positive regulation of lamellipodium organization (GO:1902745) | 2.27082574 |
| 163 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.26776155 |
| 164 | alpha-linolenic acid metabolic process (GO:0036109) | 2.26764729 |
| 165 | immunoglobulin mediated immune response (GO:0016064) | 2.26502571 |
| 166 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.25697205 |
| 167 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.23253646 |
| 168 | regulation of endothelial cell differentiation (GO:0045601) | 2.21532071 |
| 169 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.20543199 |
| 170 | negative regulation of autophagy (GO:0010507) | 2.19829759 |
| 171 | glycosphingolipid catabolic process (GO:0046479) | 2.17391293 |
| 172 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.17334114 |
| 173 | negative regulation of myotube differentiation (GO:0010832) | 2.16398227 |
| 174 | activation of MAPKKK activity (GO:0000185) | 2.16259878 |
| 175 | regulation of defense response to virus by virus (GO:0050690) | 2.15053888 |
| 176 | regulation of regulated secretory pathway (GO:1903305) | 2.14767711 |
| 177 | negative thymic T cell selection (GO:0045060) | 2.14529701 |
| 178 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.14410469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.96758343 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 2.91966601 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.74635922 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65362061 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.61977415 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.50446458 |
| 7 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.43836948 |
| 8 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.40490725 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.34461724 |
| 10 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.32075147 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25202418 |
| 12 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.24756877 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.21750544 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.11218479 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10582604 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.07986351 |
| 17 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.02801504 |
| 18 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.98861023 |
| 19 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.95281603 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.94926218 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91779912 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.87485898 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.87284223 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.83131488 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80683501 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.75295671 |
| 27 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72977643 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71323759 |
| 29 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.65876133 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63777057 |
| 31 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.63258510 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61649148 |
| 33 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60915531 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.58736625 |
| 35 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.56472916 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56125492 |
| 37 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55820654 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55456482 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54594180 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54007839 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53211165 |
| 42 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.51401879 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50228574 |
| 44 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49289861 |
| 45 | P68_20966046_ChIP-Seq_HELA_Human | 1.48844259 |
| 46 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.48228175 |
| 47 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.47779234 |
| 48 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.45667857 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45644072 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44887006 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44439933 |
| 52 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42647146 |
| 53 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39524381 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39177358 |
| 55 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37549704 |
| 56 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.37197658 |
| 57 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35582912 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35051328 |
| 59 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.33175435 |
| 60 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.32981859 |
| 61 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.32450037 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31668324 |
| 63 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30847473 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30581534 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30104192 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29336981 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.28958176 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27811157 |
| 69 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27422459 |
| 70 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27128349 |
| 71 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.26133313 |
| 72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25762613 |
| 73 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.25020919 |
| 74 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.24828289 |
| 75 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24532857 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24348476 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.23662264 |
| 78 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.23425957 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22977727 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22257686 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21361331 |
| 82 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.19782949 |
| 83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19539220 |
| 84 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.18865685 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18221981 |
| 86 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18160444 |
| 87 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18154779 |
| 88 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18084239 |
| 89 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17972800 |
| 90 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17055322 |
| 91 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.17050514 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16671437 |
| 93 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.16366029 |
| 94 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15385233 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15331345 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15212400 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14499080 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14136317 |
| 99 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14109132 |
| 100 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.13621858 |
| 101 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.13401687 |
| 102 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.13021566 |
| 103 | P300_27268052_Chip-Seq_Bcells_Human | 1.12836523 |
| 104 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12419554 |
| 105 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11827173 |
| 106 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11827173 |
| 107 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.11720387 |
| 108 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11699243 |
| 109 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11336067 |
| 110 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11024523 |
| 111 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.10767622 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10569301 |
| 113 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09932995 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09489260 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08865442 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06772657 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06042369 |
| 118 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.05783821 |
| 119 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05450300 |
| 120 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05319217 |
| 121 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05162108 |
| 122 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04530057 |
| 123 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.03640854 |
| 124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03264830 |
| 125 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03128044 |
| 126 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02941626 |
| 127 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02650851 |
| 128 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.02609066 |
| 129 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02088450 |
| 130 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.01241194 |
| 131 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.01206440 |
| 132 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.98929712 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98475311 |
| 134 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.97385426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.11651940 |
| 2 | MP0009840_abnormal_foam_cell | 3.08142136 |
| 3 | MP0003303_peritoneal_inflammation | 2.94877962 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.66902568 |
| 5 | MP0009278_abnormal_bone_marrow | 2.44636448 |
| 6 | MP0008961_abnormal_basal_metabolism | 2.39273150 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.32349238 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.30509373 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.26116493 |
| 10 | MP0005451_abnormal_body_composition | 2.25917373 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.23444959 |
| 12 | MP0001800_abnormal_humoral_immune | 2.19088354 |
| 13 | MP0001873_stomach_inflammation | 2.15910659 |
| 14 | MP0009764_decreased_sensitivity_to | 2.12052579 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.04030601 |
| 16 | MP0005671_abnormal_response_to | 1.97716962 |
| 17 | MP0002452_abnormal_antigen_presenting | 1.94180002 |
| 18 | MP0002723_abnormal_immune_serum | 1.93202720 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.91067581 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.86194337 |
| 21 | MP0004130_abnormal_muscle_cell | 1.79720713 |
| 22 | MP0004510_myositis | 1.78477044 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.77985963 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.76967452 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.74406829 |
| 26 | MP0001819_abnormal_immune_cell | 1.72803934 |
| 27 | MP0004381_abnormal_hair_follicle | 1.66556832 |
| 28 | MP0003436_decreased_susceptibility_to | 1.63679445 |
| 29 | MP0001502_abnormal_circadian_rhythm | 1.59956310 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.59040030 |
| 31 | MP0005310_abnormal_salivary_gland | 1.58479718 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.54883470 |
| 33 | MP0000685_abnormal_immune_system | 1.54293644 |
| 34 | MP0005670_abnormal_white_adipose | 1.51014865 |
| 35 | MP0002254_reproductive_system_inflammat | 1.49735774 |
| 36 | MP0004858_abnormal_nervous_system | 1.49116226 |
| 37 | MP0002877_abnormal_melanocyte_morpholog | 1.47608494 |
| 38 | MP0001348_abnormal_lacrimal_gland | 1.45826709 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.44766284 |
| 40 | MP0002933_joint_inflammation | 1.44061629 |
| 41 | MP0001958_emphysema | 1.43902616 |
| 42 | MP0001849_ear_inflammation | 1.43343235 |
| 43 | MP0005023_abnormal_wound_healing | 1.42215290 |
| 44 | MP0000751_myopathy | 1.41784324 |
| 45 | MP0004087_abnormal_muscle_fiber | 1.39114593 |
| 46 | MP0004084_abnormal_cardiac_muscle | 1.37170649 |
| 47 | MP0003283_abnormal_digestive_organ | 1.37071188 |
| 48 | MP0005375_adipose_tissue_phenotype | 1.35819861 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.35185078 |
| 50 | MP0003136_yellow_coat_color | 1.34543853 |
| 51 | MP0004947_skin_inflammation | 1.34013918 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.32226886 |
| 53 | MP0010630_abnormal_cardiac_muscle | 1.31945925 |
| 54 | MP0005083_abnormal_biliary_tract | 1.31494944 |
| 55 | MP0005360_urolithiasis | 1.31371006 |
| 56 | MP0000371_diluted_coat_color | 1.31284209 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.31271397 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.30961855 |
| 59 | MP0000716_abnormal_immune_system | 1.28322817 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.27599793 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.27233451 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.27050968 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.27050968 |
| 64 | MP0000750_abnormal_muscle_regeneration | 1.26395243 |
| 65 | MP0000733_abnormal_muscle_development | 1.24578932 |
| 66 | MP0002269_muscular_atrophy | 1.24215365 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.24000350 |
| 68 | MP0009785_altered_susceptibility_to | 1.23529715 |
| 69 | MP0001663_abnormal_digestive_system | 1.23118121 |
| 70 | MP0008469_abnormal_protein_level | 1.22705653 |
| 71 | MP0003075_altered_response_to | 1.19046141 |
| 72 | MP0003279_aneurysm | 1.17476232 |
| 73 | MP0010329_abnormal_lipoprotein_level | 1.15566605 |
| 74 | MP0000678_abnormal_parathyroid_gland | 1.14839259 |
| 75 | MP0002249_abnormal_larynx_morphology | 1.14266874 |
| 76 | MP0008260_abnormal_autophagy | 1.13714897 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 1.13548097 |
| 78 | MP0003690_abnormal_glial_cell | 1.11717978 |
| 79 | MP0005330_cardiomyopathy | 1.11685153 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.11220638 |
| 81 | MP0000609_abnormal_liver_physiology | 1.11126604 |
| 82 | MP0002822_catalepsy | 1.09922980 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 1.06389896 |
| 84 | MP0004043_abnormal_pH_regulation | 1.05009773 |
| 85 | MP0000747_muscle_weakness | 1.04665222 |
| 86 | MP0002398_abnormal_bone_marrow | 1.03109331 |
| 87 | MP0000858_altered_metastatic_potential | 1.01846889 |
| 88 | MP0003634_abnormal_glial_cell | 1.01740440 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 1.01635082 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.99589501 |
| 91 | MP0003091_abnormal_cell_migration | 0.98406290 |
| 92 | MP0005275_abnormal_skin_tensile | 0.97847235 |
| 93 | MP0000343_altered_response_to | 0.97504017 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.97496712 |
| 95 | MP0000604_amyloidosis | 0.96019747 |
| 96 | MP0002429_abnormal_blood_cell | 0.95194609 |
| 97 | MP0003045_fibrosis | 0.94170789 |
| 98 | MP0005365_abnormal_bile_salt | 0.92574268 |
| 99 | MP0006082_CNS_inflammation | 0.92341539 |
| 100 | MP0003448_altered_tumor_morphology | 0.91576492 |
| 101 | MP0000759_abnormal_skeletal_muscle | 0.91481834 |
| 102 | MP0010307_abnormal_tumor_latency | 0.90402933 |
| 103 | MP0002405_respiratory_system_inflammati | 0.90024368 |
| 104 | MP0004233_abnormal_muscle_weight | 0.89783021 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.89660534 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89623901 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.89309841 |
| 108 | MP0001790_abnormal_immune_system | 0.89196516 |
| 109 | MP0005387_immune_system_phenotype | 0.89196516 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.89183948 |
| 111 | MP0003724_increased_susceptibility_to | 0.89025046 |
| 112 | MP0005171_absent_coat_pigmentation | 0.88259325 |
| 113 | MP0008872_abnormal_physiological_respon | 0.88202494 |
| 114 | MP0003646_muscle_fatigue | 0.87809544 |
| 115 | MP0003879_abnormal_hair_cell | 0.87195359 |
| 116 | MP0005166_decreased_susceptibility_to | 0.86959551 |
| 117 | MP0010155_abnormal_intestine_physiology | 0.86208810 |
| 118 | MP0002118_abnormal_lipid_homeostasis | 0.84235273 |
| 119 | MP0009384_cardiac_valve_regurgitation | 0.84040043 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.83183675 |
| 121 | MP0005381_digestive/alimentary_phenotyp | 0.82457492 |
| 122 | MP0009643_abnormal_urine_homeostasis | 0.82453479 |
| 123 | MP0002064_seizures | 0.82246689 |
| 124 | MP0009115_abnormal_fat_cell | 0.82164215 |
| 125 | MP0000598_abnormal_liver_morphology | 0.82050310 |
| 126 | MP0003329_amyloid_beta_deposits | 0.82036559 |
| 127 | MP0002106_abnormal_muscle_physiology | 0.81931290 |
| 128 | MP0002970_abnormal_white_adipose | 0.81820876 |
| 129 | MP0005385_cardiovascular_system_phenoty | 0.80297068 |
| 130 | MP0001544_abnormal_cardiovascular_syste | 0.80297068 |
| 131 | MP0002971_abnormal_brown_adipose | 0.79985999 |
| 132 | MP0004859_abnormal_synaptic_plasticity | 0.79359149 |
| 133 | MP0003866_abnormal_defecation | 0.78906644 |
| 134 | MP0002089_abnormal_postnatal_growth/wei | 0.78478121 |
| 135 | MP0000465_gastrointestinal_hemorrhage | 0.78427043 |
| 136 | MP0005025_abnormal_response_to | 0.78412933 |
| 137 | MP0004036_abnormal_muscle_relaxation | 0.78189162 |
| 138 | MP0004808_abnormal_hematopoietic_stem | 0.78140370 |
| 139 | MP0000249_abnormal_blood_vessel | 0.77927899 |
| 140 | MP0000266_abnormal_heart_morphology | 0.77359922 |
| 141 | MP0003828_pulmonary_edema | 0.77305101 |
| 142 | MP0000681_abnormal_thyroid_gland | 0.76503362 |
| 143 | MP0005623_abnormal_meninges_morphology | 0.76192031 |
| 144 | MP0003252_abnormal_bile_duct | 0.76017372 |
| 145 | MP0000767_abnormal_smooth_muscle | 0.75673800 |
| 146 | MP0002722_abnormal_immune_system | 0.75553438 |
| 147 | MP0002796_impaired_skin_barrier | 0.74866272 |
| 148 | MP0002234_abnormal_pharynx_morphology | 0.73775961 |
| 149 | MP0001845_abnormal_inflammatory_respons | 0.73713699 |
| 150 | MP0002060_abnormal_skin_morphology | 0.73092435 |
| 151 | MP0002653_abnormal_ependyma_morphology | 0.72886409 |
| 152 | MP0000749_muscle_degeneration | 0.72610724 |
| 153 | MP0002419_abnormal_innate_immunity | 0.72534055 |
| 154 | MP0000689_abnormal_spleen_morphology | 0.72506795 |
| 155 | MP0005377_hearing/vestibular/ear_phenot | 0.66592328 |
| 156 | MP0003878_abnormal_ear_physiology | 0.66592328 |
| 157 | MP0002075_abnormal_coat/hair_pigmentati | 0.66211407 |
| 158 | MP0002063_abnormal_learning/memory/cond | 0.64293321 |
| 159 | MP0003632_abnormal_nervous_system | 0.63645398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.63305226 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.48377880 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.12428910 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.12428910 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.12428910 |
| 6 | Cerebral aneurysm (HP:0004944) | 3.91154528 |
| 7 | Asymmetric septal hypertrophy (HP:0001670) | 3.28714803 |
| 8 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 3.25102305 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.15586341 |
| 10 | Cerebellar dysplasia (HP:0007033) | 3.14054008 |
| 11 | Type II lissencephaly (HP:0007260) | 3.11672272 |
| 12 | J-shaped sella turcica (HP:0002680) | 3.10227848 |
| 13 | Hyperacusis (HP:0010780) | 3.09576090 |
| 14 | Short femoral neck (HP:0100864) | 3.08442329 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 3.03459563 |
| 16 | Distal upper limb amyotrophy (HP:0007149) | 3.01261930 |
| 17 | Upper limb amyotrophy (HP:0009129) | 3.01261930 |
| 18 | Nasal polyposis (HP:0100582) | 2.98461176 |
| 19 | Hemiplegia (HP:0002301) | 2.98384704 |
| 20 | Increased connective tissue (HP:0009025) | 2.93521169 |
| 21 | Polycythemia (HP:0001901) | 2.91758514 |
| 22 | Obstructive sleep apnea (HP:0002870) | 2.89241577 |
| 23 | Hand muscle atrophy (HP:0009130) | 2.87701639 |
| 24 | Oral leukoplakia (HP:0002745) | 2.72779440 |
| 25 | Back pain (HP:0003418) | 2.63839643 |
| 26 | Difficulty climbing stairs (HP:0003551) | 2.53843577 |
| 27 | Aneurysm (HP:0002617) | 2.53577320 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.53145977 |
| 29 | Pathologic fracture (HP:0002756) | 2.51560277 |
| 30 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.50054836 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46887530 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.46887530 |
| 33 | Abnormality of macrophages (HP:0004311) | 2.46854864 |
| 34 | Protrusio acetabuli (HP:0003179) | 2.45561051 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.45062483 |
| 36 | Stridor (HP:0010307) | 2.41055790 |
| 37 | Neurofibrillary tangles (HP:0002185) | 2.40249806 |
| 38 | Achilles tendon contracture (HP:0001771) | 2.36632128 |
| 39 | Restrictive lung disease (HP:0002091) | 2.36376224 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.35848512 |
| 41 | Upper motor neuron abnormality (HP:0002127) | 2.33670054 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.33454937 |
| 43 | Ulnar bowing (HP:0003031) | 2.33257486 |
| 44 | Abnormality of the Achilles tendon (HP:0005109) | 2.32626071 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29909025 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29909025 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29909025 |
| 48 | Difficulty running (HP:0009046) | 2.28938650 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.28879442 |
| 50 | Myositis (HP:0100614) | 2.28359053 |
| 51 | Peritonitis (HP:0002586) | 2.27955085 |
| 52 | Obstructive lung disease (HP:0006536) | 2.27454719 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27454719 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.27110789 |
| 55 | Shallow orbits (HP:0000586) | 2.25994045 |
| 56 | Myoglobinuria (HP:0002913) | 2.25297025 |
| 57 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.24768785 |
| 58 | Global brain atrophy (HP:0002283) | 2.24120887 |
| 59 | Severe muscular hypotonia (HP:0006829) | 2.23534529 |
| 60 | Hypoplasia of the pons (HP:0012110) | 2.22966596 |
| 61 | Exercise-induced myalgia (HP:0003738) | 2.22953606 |
| 62 | Neuronal loss in central nervous system (HP:0002529) | 2.22737994 |
| 63 | Mediastinal lymphadenopathy (HP:0100721) | 2.22248908 |
| 64 | Ventricular tachycardia (HP:0004756) | 2.22205390 |
| 65 | Hyporeflexia of lower limbs (HP:0002600) | 2.20882840 |
| 66 | Lymphangioma (HP:0100764) | 2.19821029 |
| 67 | Long toe (HP:0010511) | 2.19557687 |
| 68 | Myocardial infarction (HP:0001658) | 2.18930937 |
| 69 | Frequent falls (HP:0002359) | 2.17918417 |
| 70 | Deep venous thrombosis (HP:0002625) | 2.16563536 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.16194352 |
| 72 | Bundle branch block (HP:0011710) | 2.15758364 |
| 73 | Type 1 muscle fiber predominance (HP:0003803) | 2.14231877 |
| 74 | Bladder diverticulum (HP:0000015) | 2.12740439 |
| 75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.12497514 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.12497514 |
| 77 | Turricephaly (HP:0000262) | 2.10267984 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.09508879 |
| 79 | Rectal prolapse (HP:0002035) | 2.07390785 |
| 80 | Right ventricular cardiomyopathy (HP:0011663) | 2.06865281 |
| 81 | Eczematoid dermatitis (HP:0000976) | 2.05409931 |
| 82 | Systemic lupus erythematosus (HP:0002725) | 2.05171573 |
| 83 | Mitral valve prolapse (HP:0001634) | 2.02224892 |
| 84 | Sudden death (HP:0001699) | 2.00354628 |
| 85 | Broad face (HP:0000283) | 2.00300490 |
| 86 | Broad distal phalanx of finger (HP:0009836) | 2.00100696 |
| 87 | Increased density of long bones (HP:0006392) | 1.99889833 |
| 88 | Exercise-induced muscle cramps (HP:0003710) | 1.99175750 |
| 89 | Macroglossia (HP:0000158) | 1.98501802 |
| 90 | Ankle contracture (HP:0006466) | 1.98469019 |
| 91 | Retinal atrophy (HP:0001105) | 1.98451119 |
| 92 | Aortic aneurysm (HP:0004942) | 1.98378773 |
| 93 | Emphysema (HP:0002097) | 1.98267586 |
| 94 | Flared iliac wings (HP:0002869) | 1.97207595 |
| 95 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.96950296 |
| 96 | Hypercortisolism (HP:0001578) | 1.96738774 |
| 97 | Complement deficiency (HP:0004431) | 1.96698820 |
| 98 | Abnormality of the lower motor neuron (HP:0002366) | 1.95937103 |
| 99 | Supranuclear gaze palsy (HP:0000605) | 1.95665865 |
| 100 | Abnormality of the aortic arch (HP:0012303) | 1.95580007 |
| 101 | Clumsiness (HP:0002312) | 1.95044336 |
| 102 | Ulnar deviation of the wrist (HP:0003049) | 1.94427879 |
| 103 | Nuclear cataract (HP:0100018) | 1.93807180 |
| 104 | Abnormality of the pons (HP:0007361) | 1.93749923 |
| 105 | Annular pancreas (HP:0001734) | 1.92916976 |
| 106 | Broad metatarsal (HP:0001783) | 1.92160884 |
| 107 | Abnormality of the odontoid process (HP:0003310) | 1.91670462 |
| 108 | Colitis (HP:0002583) | 1.91026329 |
| 109 | Abnormality of complement system (HP:0005339) | 1.90902300 |
| 110 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90140927 |
| 111 | Insomnia (HP:0100785) | 1.89256995 |
| 112 | Hemorrhage of the eye (HP:0011885) | 1.88609063 |
| 113 | Increased serum ferritin (HP:0003281) | 1.87971751 |
| 114 | Dilatation of the ascending aorta (HP:0005111) | 1.87522284 |
| 115 | Reticulocytosis (HP:0001923) | 1.87201752 |
| 116 | Loss of speech (HP:0002371) | 1.86395798 |
| 117 | Enlarged penis (HP:0000040) | 1.86084125 |
| 118 | Gingivitis (HP:0000230) | 1.85545803 |
| 119 | Orchitis (HP:0100796) | 1.84713218 |
| 120 | Muscle fiber splitting (HP:0003555) | 1.83744869 |
| 121 | Pustule (HP:0200039) | 1.83567235 |
| 122 | Increased variability in muscle fiber diameter (HP:0003557) | 1.83145025 |
| 123 | Joint stiffness (HP:0001387) | 1.83056479 |
| 124 | Xanthomatosis (HP:0000991) | 1.81975789 |
| 125 | Abnormality of the intervertebral disk (HP:0005108) | 1.81664330 |
| 126 | Gastrointestinal infarctions (HP:0005244) | 1.81442426 |
| 127 | Onion bulb formation (HP:0003383) | 1.81103295 |
| 128 | Elfin facies (HP:0004428) | 1.80172547 |
| 129 | Recurrent skin infections (HP:0001581) | 1.79533653 |
| 130 | Abnormality of the periventricular white matter (HP:0002518) | 1.78821014 |
| 131 | Stomatitis (HP:0010280) | 1.78089729 |
| 132 | Autoimmune thrombocytopenia (HP:0001973) | 1.78040558 |
| 133 | Agammaglobulinemia (HP:0004432) | 1.78025570 |
| 134 | Thoracic kyphosis (HP:0002942) | 1.77102272 |
| 135 | Deformed sella turcica (HP:0002681) | 1.76955613 |
| 136 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.76740859 |
| 137 | Rapidly progressive (HP:0003678) | 1.76132512 |
| 138 | Disproportionate tall stature (HP:0001519) | 1.75854747 |
| 139 | Increased IgE level (HP:0003212) | 1.75592016 |
| 140 | Anomalous pulmonary venous return (HP:0010772) | 1.74731693 |
| 141 | Cerebral inclusion bodies (HP:0100314) | 1.74697617 |
| 142 | Mutism (HP:0002300) | 1.74490487 |
| 143 | Polygenic inheritance (HP:0010982) | 1.74486590 |
| 144 | Diplopia (HP:0000651) | 1.73524390 |
| 145 | Abnormality of binocular vision (HP:0011514) | 1.73524390 |
| 146 | Late onset (HP:0003584) | 1.73397727 |
| 147 | Gastrointestinal inflammation (HP:0004386) | 1.73139391 |
| 148 | Premature rupture of membranes (HP:0001788) | 1.72253401 |
| 149 | Genu recurvatum (HP:0002816) | 1.72166057 |
| 150 | Meningitis (HP:0001287) | 1.71675391 |
| 151 | Gout (HP:0001997) | 1.71027724 |
| 152 | Thin bony cortex (HP:0002753) | 1.70908972 |
| 153 | Hematochezia (HP:0002573) | 1.70328760 |
| 154 | Striae distensae (HP:0001065) | 1.70032131 |
| 155 | Limb-girdle muscle atrophy (HP:0003797) | 1.68964329 |
| 156 | EMG: neuropathic changes (HP:0003445) | 1.67878532 |
| 157 | Cervical subluxation (HP:0003308) | 1.65285867 |
| 158 | Esophageal varix (HP:0002040) | 1.65243777 |
| 159 | Impaired platelet aggregation (HP:0003540) | 1.65037666 |
| 160 | Abnormal platelet function (HP:0011869) | 1.65037666 |
| 161 | Mesangial abnormality (HP:0001966) | 1.63838274 |
| 162 | Renovascular hypertension (HP:0100817) | 1.62172080 |
| 163 | Flat acetabular roof (HP:0003180) | 1.62063514 |
| 164 | Macroorchidism (HP:0000053) | 1.59867943 |
| 165 | Nephritis (HP:0000123) | 1.59830293 |
| 166 | Chest pain (HP:0100749) | 1.58666290 |
| 167 | Atrioventricular block (HP:0001678) | 1.58617970 |
| 168 | Fibroma (HP:0010614) | 1.58205965 |
| 169 | Inflammation of the large intestine (HP:0002037) | 1.57235156 |
| 170 | Cellulitis (HP:0100658) | 1.56618582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.43966652 |
| 2 | ERN1 | 3.98725873 |
| 3 | PKN2 | 3.70702626 |
| 4 | MAP3K10 | 2.96896400 |
| 5 | EEF2K | 2.81892725 |
| 6 | TLK1 | 2.68172366 |
| 7 | ICK | 2.67259761 |
| 8 | TTN | 2.56568832 |
| 9 | RIPK1 | 2.07880695 |
| 10 | MAP4K1 | 1.98608478 |
| 11 | PTK6 | 1.97618908 |
| 12 | IRAK3 | 1.90180680 |
| 13 | MAP2K7 | 1.87360682 |
| 14 | PRKD3 | 1.80923182 |
| 15 | SIK1 | 1.72409621 |
| 16 | TNK2 | 1.66969614 |
| 17 | MAP2K4 | 1.63748917 |
| 18 | MAP3K4 | 1.62192537 |
| 19 | SMG1 | 1.61519110 |
| 20 | EPHB1 | 1.60481981 |
| 21 | LRRK2 | 1.51095227 |
| 22 | BMX | 1.49727623 |
| 23 | TAOK1 | 1.46362549 |
| 24 | TYK2 | 1.42814444 |
| 25 | CDK12 | 1.40641052 |
| 26 | RIPK4 | 1.40250622 |
| 27 | FGFR4 | 1.39408717 |
| 28 | PDGFRA | 1.36704244 |
| 29 | MAP2K6 | 1.35847715 |
| 30 | MAP3K13 | 1.24555407 |
| 31 | PRPF4B | 1.23745944 |
| 32 | PAK4 | 1.23411432 |
| 33 | GRK6 | 1.23041227 |
| 34 | IRAK4 | 1.22146376 |
| 35 | SIK2 | 1.20293210 |
| 36 | ALK | 1.16926238 |
| 37 | MAP2K3 | 1.13549752 |
| 38 | FES | 1.09918938 |
| 39 | TGFBR2 | 1.08727833 |
| 40 | STK10 | 1.08506212 |
| 41 | TBK1 | 1.05454541 |
| 42 | ZAP70 | 1.05302204 |
| 43 | MAPK12 | 1.04092225 |
| 44 | RPS6KA4 | 1.03567765 |
| 45 | MTOR | 1.02639912 |
| 46 | MAP3K11 | 1.01546453 |
| 47 | TESK1 | 1.00795008 |
| 48 | DMPK | 0.98662952 |
| 49 | PTK2 | 0.96566136 |
| 50 | MAP3K14 | 0.94666710 |
| 51 | ZAK | 0.93875109 |
| 52 | BCKDK | 0.93807992 |
| 53 | IKBKB | 0.93611052 |
| 54 | SCYL2 | 0.93377962 |
| 55 | CAMK1D | 0.92110040 |
| 56 | CSK | 0.91630652 |
| 57 | CAMK1G | 0.90706196 |
| 58 | JAK1 | 0.87465348 |
| 59 | CHUK | 0.86807526 |
| 60 | CDK6 | 0.85078832 |
| 61 | SYK | 0.83827067 |
| 62 | CAMKK1 | 0.83154073 |
| 63 | DDR2 | 0.82947392 |
| 64 | DYRK1B | 0.82634387 |
| 65 | KSR2 | 0.82166879 |
| 66 | MAP3K7 | 0.81266581 |
| 67 | NEK2 | 0.81207766 |
| 68 | PRKD2 | 0.79475633 |
| 69 | TYRO3 | 0.79447878 |
| 70 | PRKCH | 0.77904653 |
| 71 | TESK2 | 0.76092278 |
| 72 | JAK2 | 0.74494517 |
| 73 | MAP3K1 | 0.73804454 |
| 74 | LMTK2 | 0.73767078 |
| 75 | NME2 | 0.73497469 |
| 76 | RET | 0.70836248 |
| 77 | ADRBK2 | 0.70306027 |
| 78 | IKBKE | 0.70243932 |
| 79 | STK38 | 0.70177584 |
| 80 | FLT3 | 0.70009999 |
| 81 | NEK1 | 0.68614177 |
| 82 | FGR | 0.65322012 |
| 83 | RPS6KA2 | 0.64924645 |
| 84 | MAPK11 | 0.64441450 |
| 85 | PAK2 | 0.64303138 |
| 86 | LATS2 | 0.63825356 |
| 87 | CDK4 | 0.63324037 |
| 88 | ILK | 0.63316265 |
| 89 | MATK | 0.63081215 |
| 90 | MAP3K9 | 0.62831289 |
| 91 | JAK3 | 0.62470102 |
| 92 | PKN1 | 0.61608581 |
| 93 | EPHA2 | 0.61218978 |
| 94 | MAPKAPK3 | 0.60878459 |
| 95 | HCK | 0.60158252 |
| 96 | WNK4 | 0.59591422 |
| 97 | LYN | 0.59329681 |
| 98 | ITK | 0.58448036 |
| 99 | PRKD1 | 0.57841839 |
| 100 | TAOK3 | 0.57356639 |
| 101 | RPS6KC1 | 0.56769511 |
| 102 | RPS6KL1 | 0.56769511 |
| 103 | RPS6KA1 | 0.56157891 |
| 104 | NTRK3 | 0.55512364 |
| 105 | MAP3K6 | 0.54679815 |
| 106 | MAP3K8 | 0.54642988 |
| 107 | FGFR3 | 0.53977072 |
| 108 | CAMKK2 | 0.53945254 |
| 109 | HIPK2 | 0.53758320 |
| 110 | PDK4 | 0.53345338 |
| 111 | PDK3 | 0.53345338 |
| 112 | RPS6KA6 | 0.53283909 |
| 113 | PDPK1 | 0.52844654 |
| 114 | MAP2K2 | 0.50110724 |
| 115 | PDK1 | 0.49293272 |
| 116 | PRKAA1 | 0.49100864 |
| 117 | PDGFRB | 0.48730800 |
| 118 | EPHA3 | 0.48725612 |
| 119 | IRAK1 | 0.48179233 |
| 120 | KDR | 0.47219538 |
| 121 | DAPK2 | 0.45872638 |
| 122 | LCK | 0.45668715 |
| 123 | PTK2B | 0.45219166 |
| 124 | MAPK15 | 0.45191672 |
| 125 | PHKG1 | 0.44535288 |
| 126 | PHKG2 | 0.44535288 |
| 127 | RPS6KA5 | 0.43834923 |
| 128 | BTK | 0.43830003 |
| 129 | PRKG2 | 0.43616630 |
| 130 | PRKCI | 0.41842262 |
| 131 | TAOK2 | 0.41327648 |
| 132 | STK11 | 0.40726724 |
| 133 | BLK | 0.40583657 |
| 134 | MAP3K3 | 0.40495375 |
| 135 | KIT | 0.39902074 |
| 136 | CDC42BPA | 0.39646190 |
| 137 | DAPK3 | 0.39615106 |
| 138 | CAMK4 | 0.37859431 |
| 139 | MARK2 | 0.37759088 |
| 140 | TXK | 0.37714066 |
| 141 | CSF1R | 0.37203985 |
| 142 | PRKCZ | 0.36885310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.37531253 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09121142 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73612442 |
| 4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.73109986 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.70570375 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.59973740 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58494240 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.55331793 |
| 9 | Insulin resistance_Homo sapiens_hsa04931 | 1.55032957 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.51512095 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.49964558 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47933666 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46273406 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44579742 |
| 15 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.41891405 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38066493 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37595240 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.37197637 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.36649702 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36396523 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34035379 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.33967438 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.33783339 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.33067962 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32560509 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31000245 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.30909388 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.30042095 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30024962 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.29736682 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25953478 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25133928 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.23660866 |
| 34 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.20271442 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.20267505 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19909788 |
| 37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.19786698 |
| 38 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.16735235 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16412870 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15525453 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15479304 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.13532665 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13211363 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.12767683 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12505085 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09461785 |
| 47 | * Lysosome_Homo sapiens_hsa04142 | 1.09361571 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 1.09006786 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08070200 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.07018087 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06661475 |
| 52 | Focal adhesion_Homo sapiens_hsa04510 | 1.06483685 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05649259 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 1.05386732 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01060951 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00826043 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.00494386 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99861174 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 0.98789767 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.98409258 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98369740 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.97765175 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.97302944 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96799916 |
| 65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.95437500 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95390508 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94479783 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93190582 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92404277 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91994169 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90270238 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90144759 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89820924 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89699627 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.88726686 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87818084 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87458706 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.87314392 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.86632211 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86476232 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86251753 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86087941 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85981568 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85967464 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85401600 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.84996790 |
| 87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84555048 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84088543 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84086374 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83748412 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82131492 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82080476 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81956001 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81794192 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81427254 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81046504 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80890737 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80710942 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.79988530 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78881730 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76949468 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.76847875 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76161127 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76013474 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.75771596 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75638118 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.74828216 |
| 108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71914212 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.71179296 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69807162 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68523061 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67951461 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67453354 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67414938 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.67181666 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67055897 |
| 117 | Legionellosis_Homo sapiens_hsa05134 | 0.66934412 |
| 118 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66741742 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66654315 |
| 120 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66165015 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65538945 |
| 122 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64295225 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63901554 |
| 124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63368289 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63272303 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.62849537 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.62592916 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61279250 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.60627657 |
| 130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60189750 |
| 131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60162669 |
| 132 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60010758 |
| 133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59397731 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59161023 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58040619 |
| 136 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56919327 |
| 137 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56592640 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54982020 |
| 139 | Salmonella infection_Homo sapiens_hsa05132 | 0.54916259 |
| 140 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54913620 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.54806475 |
| 142 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53743940 |
| 143 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53272532 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52549481 |
| 145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51067545 |
| 146 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49724063 |
| 147 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49484503 |
| 148 | Insulin secretion_Homo sapiens_hsa04911 | 0.48592878 |
| 149 | Malaria_Homo sapiens_hsa05144 | 0.46941649 |
| 150 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45937998 |
| 151 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.44508692 |

